-
A Comprehensive Review of Advances in Molecular Mechanisms and Targeted Therapies for the Specific Type of Cystic Lung Cancer
11 Feb 2025 15:06 GMT
… is the most neuroendocrine lung tumor, and it also … Lung cancers associated with cystic airspaces: CT features and pathologic correlation. Lung Cancer … -L1 expression in rare lung tumors. Pathol Oncol Res. … phase II study of sunitinib in recurrent and…
-
ESMO 2025: Lunit’s AI tool predicts immunotherapy response across cancer types
16 Oct 2025 02:49 GMT
… plus ipilimumab (NIVO+IPI) or sunitinib (SUN).
SCOPE IO was applied … response in non-small cell lung cancer (NSCLC) patients.
In the study …
-
Chemoradiotherapy with or Without Anlotinib for Postoperative Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma: A Real-World Observational Study
15 Oct 2025 22:15 GMT
… hepatocellular carcinoma, non-small cell lung cancer (NSCLC), and ESCC.8 … extensive-stage small-cell lung cancer after second-line or … association for the study of lung cancer (IASLC) lymph node map … et al. Anlotinib versus sunitinib as first-line treatment for …
-
Lenvatinib Plus Pembrolizumab Delays Tumor Progression in All Organs vs Sunitinib in Advanced RCC
05 Jun 2024 18:17 GMT
… in all organs vs sunitinib (Sutent) in patients with advanced … organ groups. In the lung tumor group, the median time … lenvatinib and pembrolizumab compared with sunitinib,” Viktor Grünwald, MD, … of patients who received sunitinib,” Grünwald said in conclusion …
-
Angiogenesis and Immunosuppressive Niche in Hepatocellular Carcinoma: Reshaping Vascular - Immune Axis to Potentiate antiPD - 1/PD - L1 Therapy
29 Sep 2025 07:04 GMT
… , et al. Influence of bevacizumab, sunitinib and sorafenib as single agents … treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction …
-
The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
02 Aug 2022 00:04 GMT
… to 15% of all lung cancers.1 SCLC comprises … chemotherapy for small cell lung cancer. Lung Cancer. 2006;52(3 … sunitinib in patients with relapsed or refractory small cell lung cancer. Lung Cancer … with relapsed small cell lung cancer. Lung Cancer. 2016;96:108– …
-
Ipsen: ASCO 2022: New Cabometyx® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer
26 May 2022 21:17 GMT
… demonstrated deeper responses vs sunitinib. Regardless of treatment, … non-small cell lung cancer (NSCLC)
Lung cancer is one of … of lung cancer - NSCLC and SCLC (small cell lung cancer). … Organization: GLOBOCAN 2020 – Lung Cancer: Estimated cancer incidence, …
-
Eight-Year Data for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Continue to Demonstrate Longest Survival Benefit vs. Sunitinib Reported in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
22 Jan 2024 22:20 GMT
… seeing sustained benefits over sunitinib in the primary … node positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non–small cell lung cancer, …
-
Identifying Chemokine System-Related Phenotype to Predict Immune Feature in Pan-Cancer and Prognostic Signature for Lung Adenocarcinoma
22 Sep 2025 13:16 GMT
… rapamycin, roscovitine, and sunitinib exhibited a negative correlation with … the proliferation of lung cancer cells.28 Multiple … -promoted proliferation of lung cancer cells through targeting CCL5 … al. Enhance anti-lung tumor efficacy of chimeric antigen …
-
HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS® in Lung Cancer
07 Mar 2022 06:00 GMT
… savolitinib plus IMFINZI® versus sunitinib monotherapy versus IMFINZI® … caregivers/lung-cancer-101/types-of-lung-cancer . Accessed … lung cancer – A systematic review and meta-analysis. Lung Cancer 2018 … non-small-cell lung cancers harbouring MET exon …
About
© 1995-2025